NatureWise Biotech & Medicals Corporation (4732.TWO)
TWD 19.4
(-8.92%)
TWD 19.4
(-8.92%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 83.94 Million TWD | -20.63% |
| 2022 | 92.64 Million TWD | -14.16% |
| 2021 | 107.91 Million TWD | -4.89% |
| 2020 | 113.46 Million TWD | -11.57% |
| 2019 | 128.31 Million TWD | 78.09% |
| 2018 | 72.05 Million TWD | -19.59% |
| 2017 | 89.6 Million TWD | -0.04% |
| 2016 | 89.63 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 33.31 Million TWD | -23.43% |
| 2024 Q2 | 33.31 Million TWD | 0.0% |
| 2023 Q2 | 30.01 Million TWD | 70.56% |
| 2023 FY | 73.52 Million TWD | -20.63% |
| 2023 Q3 | 24.37 Million TWD | -18.81% |
| 2023 Q1 | 17.59 Million TWD | -62.59% |
| 2023 Q4 | 43.51 Million TWD | 78.52% |
| 2022 Q2 | 45.59 Million TWD | 0.0% |
| 2022 Q4 | 47.04 Million TWD | 0.0% |
| 2022 FY | 92.64 Million TWD | -14.16% |
| 2021 Q2 | 52.48 Million TWD | 0.0% |
| 2021 Q4 | 55.42 Million TWD | 0.0% |
| 2021 FY | 107.91 Million TWD | -4.89% |
| 2020 FY | 113.46 Million TWD | -11.57% |
| 2020 Q4 | 60.29 Million TWD | 0.0% |
| 2020 Q2 | 53.16 Million TWD | 0.0% |
| 2019 Q4 | 68.4 Million TWD | 0.0% |
| 2019 FY | 128.31 Million TWD | 78.09% |
| 2018 FY | 72.05 Million TWD | -19.59% |
| 2017 FY | 89.6 Million TWD | -0.04% |
| 2016 FY | 89.63 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -25415.198% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 34.248% |
| Level Biotechnology Inc. | 151.99 Million TWD | 44.77% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 38.209% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | -10.659% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 62.73% |
| GlycoNex Incorporation | 995 Thousand TWD | -8336.683% |
| VBI | 32.55 Million TWD | -157.856% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 67.32% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 56.771% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -82.398% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 29.993% |
| Visgeneer Inc. | 67.48 Million TWD | -24.396% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 122.374% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 83.543% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -31.363% |
| Neith Corporation | 66.87 Million TWD | -25.529% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 94.187% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -185.994% |
| Enimmune corporation | 220.1 Million TWD | 61.861% |
| TaiRx, Inc. | 217.13 Million TWD | 61.34% |
| CHO Pharma, Inc. | 268.99 Million TWD | 68.793% |
| EirGenix Inc. | 236.74 Million TWD | 64.541% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 19.555% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 76.527% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 92.347% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 68.461% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | -69.685% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -7651.154% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 52.694% |
| RBC Bioscience Corporation | 58.35 Million TWD | -43.85% |
| BiOptic Inc. | 108.69 Million TWD | 22.768% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -93172.222% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -21.045% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -3110.134% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 86.963% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 10.061% |
| NaviFUS Corp. | 11.82 Million TWD | -609.774% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 55.987% |
| Sinew Pharma Inc. | 186.25 Million TWD | 54.93% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -13.404% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 61.912% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -102.37% |
| AP Biosciences Inc | 32.25 Million TWD | -160.27% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 95.463% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -1491.676% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 73.546% |
| Intech Biopharm Corporation | -163.99 Million TWD | 151.188% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 92.566% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -102.365% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 50.491% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 42.903% |
| TCI GENE Inc. | 174.61 Million TWD | 51.926% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -466261.111% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 72.106% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 71.149% |
| PharmaEngine, Inc. | 441.78 Million TWD | 80.999% |
| Savior Lifetec Corporation | 223.36 Million TWD | 62.419% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 67.561% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 95.837% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 39.551% |
| Acepodia, Inc. | 452.56 Million TWD | 81.451% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 84.482% |